Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients ...
AI in oncology nursing remains in its early stages, but it’s already reshaping health care. This moment was evident at the 2025 American Society of Hematology Annual Meeting and Exposition, which ...
The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...
Emese Zsiros, MD, PhD, FACOG, discusses managing paclitaxel toxicity and the role of pembrolizumab maintenance in treating ...
Leopold, MD, explains how evidence-based integrative therapies like acupuncture and nutrition improve oncology patient ...
The FDA has approved acalabrutinib plus venetoclax in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The FDA has approved the use of acalabrutinib (Calquence) tablets ...
Watch the latest shorts from Oncology Nursing News ...
Recent regulatory actions from the FDA, including new drug application (NDA) acceptances and labeling updates, introduce new clinical considerations for oncology nurses and advanced practice providers ...
Welcome to Onc Nurse On Call, the new podcast from Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, AOCN, and Stephanie Desrosiers, DNP, MSN, RN, AOCNS, BMTCN, delivering ...
The FDA has approved Optune Pax, a wearable medical device that delivers Tumor Treating Fields (TTFields), for the treatment of adult patients with locally advanced pancreatic cancer (LA-PAC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results